Earnings Feed
Start Free
BECTON DICKINSON & CO·4

Jan 16, 3:43 PM ET

Garrison Michael David 4

4 · BECTON DICKINSON & CO · Filed Jan 16, 2026

Insider Transaction Report

Form 4
Period: 2026-01-15
BECTON DICKINSON & COBDX
Garrison Michael David
EVP & Pres Med.Essntl&BioPharm
Transactions
  • Exercise/Conversion

    Common Stock

    2026-01-15$167.91/sh+3,054$512,797→ 16,159 total
  • Disposition to Issuer

    Common Stock

    2026-01-15$209.00/sh−2,454$512,886→ 13,705 total
  • Sale

    Common Stock

    2026-01-15$209.00/sh−600$125,400→ 13,105 total
  • Sale

    Common Stock

    2026-01-15$206.54/sh−1,010$208,605→ 12,095 total
  • Exercise/Conversion

    Stock Appreciation Rights

    [F1]
    2026-01-15−3,054→ 0 total
    Exercise: $167.91From: 2017-11-26Exp: 2026-11-26→ Common Stock (3,054 underlying)
Footnotes (1)
  • [F1]The stock appreciation rights vested in four annual installments beginning one year from the grant date.
Signature
Donna Kalazdy, by power of attorney from Michael David Garrison|2026-01-16

Documents

1 file
  • 4
    wk-form4_1768596224.xmlPrimary

    FORM 4